New insulin receptor agonists
TW202626703APending Publication Date: 2026-07-01OOO GEROPHARM
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114145045
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-19
- Filing Date
- 2025-11-19
- Publication Date
- 2026-07-01
Abstract
The invention relates to the field of biotechnology, namely to novel insulin receptor agonists, and can be used in medicine. The provided ultra-long-acting insulin receptor agonists are a fusion protein comprising insulin or an analog thereof fused to an Fc fragment polypeptide having a high binding capacity for FcRn and a low binding capacity for FcγRs.
Need to check novelty before this filing date? Find Prior Art